250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science VC Funds in Spain

A list of 50 VC funds that invest in Life science startups based in Spain. We rank investors based on the number of investments they made in Life science companies from Spain. We update this investor list every month.

Top 50 Life Science VC Funds in Spain

Investor Life Science Spain investments
Centre for the Development of Industrial Technology (CDTI) 8
Bullnet Capital 7
Capital Cell 7
Asabys Partners 4
ENISA 4
Invivo Capital Partners 3
Inveready 3
Criteria Venture Tech 2
Nara Capital 2
Charme Capital Partners 2
Demium Capital 2
Josep Carreras Leukaemia Research Institute 2
Ysios Capital 2
Amino Collective 2
Amadeus Capital Partners 2
Xesgalicia 2
Speedinvest 2
Alta Life Sciences 2
BStartup 2
Monte Carlo Capital 2
BoxOne Ventures 2
Talis Capital 2
Global health sciences venture fund 1
CRB Inverbío 1
Veg Capital 1
Ezten Venture Capital Fund 1
Green Generation Fund 1
Grupo Ferrer Internacional 1
Good Seed Ventures 1
Debiopharm Innovation Fund 1
BAGi 1
CDTI 1
Inveniam 1
Gilde Healthcare 1
Catalan Institution for Research and Advanced Studies 1
mVenturesBCN 1
Innova-Tech Consulting 1
BCN PEPTIDES 1
Fund+ 1
Stemar Capital 1
GENESIS Biomed 1
Clave Capital 1
Alma Mundi Ventures 1
Addition 1
Fides Capital 1
Banc Sabadell and the Institut Català de Finances (ICF) 1
Novartis Venture Fund 1
Pontifax 1
New Enterprise Associates 1
UCB Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Centre for the Development of Industrial Technology (CDTI) VC Fund · Madrid, Madrid, Spain · 18 investments in the past 12 months
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Seed, Grant
  • Spain, United States, France
Portfolio highlights
  • SOLATOM — SOLATOM sells solar steam to industries with thermal processes. Solatom is a solar concentrator designed for generating high temperature heat (steam, hot water or thermal oil) in industrial processesSolatom's modules are formed by rows of mirrors that track the sun , reflecting the sunlight on a vacuum tube. The fluid circulating through thetube absorbs the reflected energy producing an increase in the temperature of the fluid (up to 300 ° C ). Each module has a nominal power of 15kW thermal. When more capacity is needed, the modules are joined together, increasing the total power of the plant. The system is designed for be deployed on the rooftop, being its specific weight less than 23 kg/m 2 .
  • IENAI SPACE — IENAI SPACE develops efficient ionic-liquid electric propulsion systems and mission analysis for nano-satellites. The company provides propulsion modules customized for each particular platform and mission, from 2U to 12U, from RAAN-spacing to Earth-Moon transits or de-orbiting.Its versatile Tailored Taylor Thruster is highly scalable in specificimpulse and thrust. It is based on a novel iteration of electrospray thrusters, which boast high theoretical efficiencies for electric propulsion technologies in the low power range. In combination with its decreased form factor, meaning less propellant on-board, making this technology attractive in constrained volumes.IENAI SPACE was founded in 2019 and is headquartered in Madrid, Spain.
  • Trovant Technology — Trovant Technology specializes in the development of bio-based technologies for organic waste treatment and valorization, transforming this waste into bioenergy. They develop proprietary technology and tailor-made solutions, always keeping the market in mind. At the moment they are focusing on biogas upgrading and biomethane with UBI - BiologicalIntegral Biogas Upgrading.
Bullnet Capital VC Fund · Pozuelo De Alarcón, Madrid, Spain · 3 investments in the past 12 months
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more
Investment focus
  • Software, Information Technology, Enterprise Software
  • Funding Round, Seed, Series A
  • Spain, United States, Mexico
Portfolio highlights
  • MLCode — Accelerated by massive AI/ML adoption, Data is to become the most critical resource for Enterprises. MLCode vision is to protect that Data. MLCode: Data Security Automation.
  • FYLA — At FYLA we create unique All-fiber Ultrafast pulsed lasers by Joining Singularity with Quality. Discover our multiphoton and two photon lasers!
  • Mapsi Photonics — Mapsi Photonics focuses on developing macroporous silicon infrared filters for industrial applications like gas identification and thermal vision, aiming to improve performance, cost, resolution, operational range, and environmental footprint.
Capital Cell VC Fund · Barcelona, Catalonia, Spain
Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Equity Crowdfunding, Funding Round, Seed
  • Spain, United States, United Kingdom
Portfolio highlights
  • Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
  • MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Asabys Partners VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more
Investment focus
  • Biotechnology, Medical Device, Health Care
  • Series A, Seed, Series B
  • Spain, France, Belgium
Portfolio highlights
  • AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
  • Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
  • Gradient Denervation Technologies — Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.
ENISA VC Fund · Madrid, Madrid, Spain · 34 investments in the past 12 months
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Debt Financing, Pre-Seed
  • Spain, United States, France
Portfolio highlights
  • Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
  • Banktrack — Banktrack provides All the bank movements by Email, WhatsApp, or your favorite channel.
  • Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
Invivo Capital Partners VC Fund · Barcelona, Catalonia, Spain · 2 investments in the past 12 months
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Seed, Funding Round, Series A
  • Spain, France, Belgium
Portfolio highlights
  • EsoBiotec — EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.EsoBiotec's objective is to enable the human body to fight cancer by delivering 'in vivo' cell engineering to patients.
  • Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
  • OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Inveready VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
We are a leading asset manager in Spain. We invest in early-stage VC, growth VC, venture debt, strategic public equity, private equity and infrastructure. Our different strategies allow us to provide financing solutions to companies throughout their life-cycle.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Funding Round, Series A
  • Spain, United States, United Kingdom
Portfolio highlights
  • Nanusens — Nanusens shrinks MEMS sensors and builds nanoscale sensors (NEMS – Nano Electro Mechanical Systems) along with the control electronics using standard CMOS processes.
  • IENAI SPACE — IENAI SPACE develops efficient ionic-liquid electric propulsion systems and mission analysis for nano-satellites. The company provides propulsion modules customized for each particular platform and mission, from 2U to 12U, from RAAN-spacing to Earth-Moon transits or de-orbiting.Its versatile Tailored Taylor Thruster is highly scalable in specificimpulse and thrust. It is based on a novel iteration of electrospray thrusters, which boast high theoretical efficiencies for electric propulsion technologies in the low power range. In combination with its decreased form factor, meaning less propellant on-board, making this technology attractive in constrained volumes.IENAI SPACE was founded in 2019 and is headquartered in Madrid, Spain.
  • Scaleup Finance — Improve your financial management
Criteria Venture Tech VC Fund · Barcelona, Catalonia, Spain · 7 investments in the past 12 months
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Pre-Seed to Series C) managing more than €300M of AUM.
Show more
Investment focus
  • Software, Biotechnology, E-Commerce
  • Seed, Funding Round, Series A
  • Spain, United States, United Kingdom
Portfolio highlights
  • Enline — Technology for Power Systems, TRANSMISSION AND DISTRIBUTION SYSTEM OPERATORS, INDUSTRY AND MINING, ENGINEERING & CONSTRUCTION, INSURANCE AND CONSULTANCY, UTILITIES & POWER GENERATION, ENLINE MONITORING SYSTEM, ENLINE DYNAMIC LINE RATING, ENLINE FAULT LOCATION, ENLINE POWER OPTIMIZATION .
  • Argilla — The labelling platform designed for modern MLOps. Label and improve your data with multiple feedback loops. Bridge the gap between training and production data. From experimentation to production, Argilla helps domain experts and data teams to build better NLP datasets in less time.
  • KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!
Nara Capital VC Fund · Barcelona, Catalonia, Spain · 2 investments in the past 12 months
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more
Investment focus
  • Life Science, Biotechnology, Medical
  • Seed, Funding Round
  • Spain
Portfolio highlights
  • MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
  • OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Charme Capital Partners VC Fund · Milano, Lombardia, Italy
Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more
Investment focus
  • Genetics, Life Science, Biotechnology
  • Series A
  • Spain
Portfolio highlights
  • Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Demium Capital VC Fund · Valencia, Comunidad Valenciana, Spain
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Pre-Seed, Seed, Series A
  • Spain, Portugal, Poland
Portfolio highlights
  • Coolx — Coolx has a mission to bring technology to the service of forests. Through satellite technology and AI we help environmental consultancies, engineers and forestry managers to optimize the analysis, management and forest conservation.
  • Holaglow — Holaglow is an aesthetic medicine and cosmetic dermatology provider of personalized services.
  • Nuwe — Nuwe is a startup disrupting how tech professionals get hired and improve their skills, while at the same time it changes the way companies do people management and recruitment. To achieve that,we have developed a gamified platform which allows users to take challenges, participate in projects and contribute to Nuwe’s community sharing knowledgeand helping other users out. All of this contributes to their path to getting a job and their professional self-development.Companies can ask for personalized challenges, getting access to a database of validated users. For companies, wanting to participate in Nuwe’s selection processes not only get a database of validated users, but they generate a huge impact within tech communities which helps them gain a better reputation and have access to more qualified talent in the future. Moreover, companies can also ask for internal employee analytics which will help them optimize their overall performance.
Josep Carreras Leukaemia Research Institute VC Fund · Badalona, Catalonia, Spain
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Spain
Portfolio highlights
Ysios Capital VC Fund · San Sebastian, Pais Vasco, Spain · 6 investments in the past 12 months
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Spain, United States, Switzerland
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
  • Engrail Therapeutics — Engrail delivers transformational therapies that improve the lives of patients with devastating neurologic, neuropsychiatric, and neurodevelopmental disorders.
Amino Collective VC Fund · Berlin, Berlin, Germany · 6 investments in the past 12 months
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Pre-Seed
  • United States, Germany, United Kingdom
Portfolio highlights
  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • ExpressionEdits — Redefining the status quo of protein expression
  • Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Amadeus Capital Partners VC Fund · Cambridge, Cambridgeshire, United Kingdom · 5 investments in the past 12 months
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Series B, Seed, Series A
  • United Kingdom, United States, Spain
Portfolio highlights
  • Sitehop — Sitehop is a technology company creating innovative solutions for cyber-security and networking. Sitehop utilizes its custom FPGA solutions to optimize and accelerate cloud/telco networks.
  • Secondmind — Helping automotive engineers design better cars, faster.
  • Photonic — We are building a new world through scalable, fault-tolerant quantum technologies.
Xesgalicia VC Fund · Santiago De Compostela, Galicia, Spain · 2 investments in the past 12 months
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more
Investment focus
  • Software, Biotechnology, Pharmaceutical
  • Seed, Funding Round, Pre-Seed
  • Spain, Portugal
Portfolio highlights
  • Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
  • Appentra — In the software world, new technologies have recently put on the hands of companies and developers highly powerful tools which involve a leap in computing capabilities. First, heterogeneous multicore systems have become small and affordable supercomputers. Second, Artificial Intelligence, Machine Learning, Deep Learning, and big data arerevolutionizing entire economic sectors. These powerful tools were up until now only accessible to a minority of organizations with massive resources but finally they have become mainstream. However, to take advantage of these powerful capabilities, companies need to adopt the computing technologies created for years in (HPC) market, particularly parallel computing. PARALLELWARE ANALYZER is the most complete and fast software aimed to enable developers to overcome the complexity of parallel programming. Appentra is a Deep Tech global company that delivers products based on the Parallelware technology, a unique approach to static code analysis specialized in concurrency and parallelism. Our aim is to make parallel programming easier, enabling everyone to make the best use of parallel computing hardware from the multi-cores in a laptop to the fastest supercomputers.
  • Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
Speedinvest VC Fund · Vienna, Wien, Austria · 44 investments in the past 12 months
Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • planqc — planqc quantum computers store information in individual atoms – nature's best qubits. Quantum information is processed by arranging these qubits in highly scalable arrays and manipulating them with precisely controlled laser pulses. planqc unique combination of quantum technologies is the fastest way to scale to thousands of qubits, aprerequisite for industry-relevant quantum advantage.
  • Prewave — Supplier monitoring for purchasing, supply chain management and sustainability managers.
  • forward earth — Next-Gen carbon management for a sustainable future. AI-driven, automated, compliant, fast, and secure. Be prepared for requirements of CSRD, SFRD, EU-Taxonomy, and kick-start your carbon reduction and abatement program. White-label options for partners.
Alta Life Sciences VC Fund · Barcelona, Catalonia, Spain
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Series A, Funding Round, Seed
  • Spain, United States
Portfolio highlights
  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
  • Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.
BStartup VC Fund · Sant Cugat Del Vallès, Catalonia, Spain · 6 investments in the past 12 months
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Funding Round, Pre-Seed
  • Spain, United States
Portfolio highlights
  • toddl.co — Book classes, camps and events for your kids in less than 3 clicks
  • Remuner — The AI-powered variable compensation platform that helps you align your company and employee goals by automating all aspects of incentive plans.
  • Emely AI — Emily.AI enables the adaptation to various environments and patient conditions, reducing or eliminating the need for medical supervision. The company has developed an oxygen therapy medical device that uses artificial intelligence to dynamically adjust to each patient's specific needs.
Monte Carlo Capital VC Fund · Monaco, Bayern, Germany · 2 investments in the past 12 months
Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).
Show more
Investment focus
  • Medical Device, Financial Services, Medical
  • Seed, Funding Round, Series A
  • United States, United Kingdom, Spain
Portfolio highlights
  • LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
  • Rollstack — Rollstack is a tool that helps you create stunning and high-quality charts in minutes, embed data, and automate the creation of data-driven decks and docs - all within your favorite tools (Google Suite, Notion, Powerpoint)
  • Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit
BoxOne Ventures VC Fund · Montréal, Quebec, Canada · 2 investments in the past 12 months
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Pre-Seed, Series A
  • Canada, United States, Spain
Portfolio highlights
  • BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
  • HumanFirst — The complete productivity suite to transform natural language into business insights and AI training data
  • Pathway Medical — Pathway is an accurate and efficient point-of-care reference tool that gives you rapid access to evidence-based guideline summaries, interactive algorithms, key findings from landmark trials, clinical calculators, and more. Available anytime, anywhere.
Talis Capital VC Fund · London, England, United Kingdom
We back founders who see the future differently.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Acin — Acin delivers at speed by combining unique industry data, AI and high touch expertise. The trusted partner, built by the industry, for the industry
  • Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
  • Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
Global health sciences venture fund VC Fund · Vancouver, British Columbia, Canada
The strength of the life science industry here and the quality of its technologies. We anticipate that internationally competitive Canadian companies will do well having a fund of this size and calibre at their doorstep, and we believe such a fund will energize the sector and be a magnet for further capital."
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series C, Series A, Series B
  • United States, Canada, Spain
Portfolio highlights
  • EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
  • Variantyx — Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing.
  • CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.
CRB Inverbío VC Fund · Madrid, Madrid, Spain
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Funding Round, Seed
  • Spain, Mexico
Portfolio highlights
  • Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
  • Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
  • Aglaris Ltd — Aglaris is developing an automated cell culture bioreactor for the mass production of human stem cells.Aglaris produces equipment to ensure cell and tissue culture is an easy, problem-free task. By automating and controlling the cell culture processes, we can obtain cells and tissues with sufficient quality to revitalize regenerative medicine andcell therapies. The technology used by our equipment is unique and is protected by international patents.
Veg Capital VC Fund · Loughborough, Leicestershire, United Kingdom · 2 investments in the past 12 months
Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.
Show more
Investment focus
  • Food and Beverage, Biotechnology, Restaurants
  • Seed, Equity Crowdfunding, Pre-Seed
  • United Kingdom, Sweden, Brazil
Portfolio highlights
  • Super Vegan — Loja de chocolates veganos
  • SpiceBox — SpiceBox is your local, award-winning curry house in Walthamstow & Leytonstone. We serve fresh and flavourful Indian food that happens to be vegan. Carefully crafted, freshly made with bags of character and style. We're open for dinner Tues-Sun and brunch on the weekends. We also offer zero-emissions delivery.
  • THE PACK — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
Ezten Venture Capital Fund VC Fund
Ezten Venture Capital Fund
Show more
Investment focus
  • Software, Automotive, Clean Energy
  • Funding Round, Seed
  • Spain
Portfolio highlights
  • EPowerlabs — EPowerlabs offers electric mobility components both in passenger car and heavy duty segments to help OEM and Tier 1 build electric cars
  • Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
  • Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Green Generation Fund VC Fund · Berlin, Berlin, Germany · 4 investments in the past 12 months
The Green Generation Fund invests in early stage Food Tech and Green Tech companies that make our lives and diets more sustainable, healthy and ethical.
Show more
Investment focus
  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, United States, Spain
Portfolio highlights
  • Reverion — Reverion offers electrical efficiencies for both power generation and energy storage. Reverion was foun ded in 2022 and was headquartered in Bayern, Germany.
  • smatch — Smatch takes care of stock management and helps retailers to better buy merchandise.
  • Change Foods — We (re)create real dairy foods that delight the taste buds, nourish people and sustain the planet, by using the magic of microbes instead of animals.
Grupo Ferrer Internacional VC Fund · Barcelona, Catalonia, Spain
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more
Investment focus
  • Biotechnology, Wellness, Biopharma
  • Series A, Funding Round
  • Spain
Portfolio highlights
  • Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
  • ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.
Good Seed Ventures VC Fund · Rheine, Nordrhein-Westfalen, Germany
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more
Investment focus
  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Series A, Pre-Seed
  • Germany, Israel, United States
Portfolio highlights
  • Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
  • Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Debiopharm Innovation Fund VC Fund · Lausanne, Vaud, Switzerland
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • Switzerland, United States, France
Portfolio highlights
  • Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
  • Genialis — Genialis is a precision medicine data science company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at the intersection of clinical and translational medicine and drug discovery. Genialis is trusted by biopharma and big pharma alike, to validate targets, predict biomarkersand optimally position novel drugs. Together, Genialis and its partners are bringing improved solutions to drug discovery to change people's lives.
  • Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
BAGi VC Fund · Girona, Catalonia, Spain
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more
Investment focus
  • Internet, Health Care, Information Technology
  • Seed, Angel, Funding Round
  • Spain, Norway, Switzerland
Portfolio highlights
  • Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
  • Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
  • The Smart Lollipop — The Smart Lollipop is the non-invasive medical device in the shape of a lollipop for the diagnostic and disease monitoring through a saliva sample. The sweetest lab is The Smart Lollipop.
CDTI VC Fund · Ventura, California, United States
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Debt Financing
  • Spain, United States, Mexico
Portfolio highlights
  • Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
  • Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
  • Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Inveniam VC Fund · Barcelona, Catalonia, Spain
Supporting impact innovators to bring their breakthrough technologies to the market, for a healthier, safer and more sustainable world.
Show more
Investment focus
  • Biopharma, Health Care, Life Science
  • Seed, Funding Round
  • Spain
Portfolio highlights
  • AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
  • NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
Gilde Healthcare VC Fund · Utrecht, Utrecht, The Netherlands
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series C, Series A
  • United States, The Netherlands, Germany
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Argá Medtech — Developing the next generation of Pulsed Field Ablation and Irreversible Electroporation Venture-capital backed company
  • GT Medical Technologies — At GT Medical Technologies, our purpose is Improving the Lives of Patients with Brain Tumors. GammaTile Therapy is Surgically Targeted Radiation Therapy (STaRT) for patients with brain tumors.
Catalan Institution for Research and Advanced Studies VC Fund
ICREA is a foundation supported by the Catalan Government for the advancement of research.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Spain
Portfolio highlights
mVenturesBCN VC Fund · Barcelona, Catalonia, Spain
mVenturesBcn is a new player in the field of innovation.
Show more
Investment focus
  • Biopharma, Health Care, Life Science
  • Seed
  • Spain
Portfolio highlights
  • RheoDx — We provide a new way to measure the behavior of blood in motion. RHEO Dx can detect, with a sample of blood as small as a drop, minimum changes in rheological properties, that are an indicator of abnormalities in red blood cells morphology or rigidity. These abnormalities are associated with an enormous set of diseases and conditions, such as bloodcoagulation disorders , malignant homeopathies, malaria, hereditary anaemias, and any other disease related to blood cells rheology.
Innova-Tech Consulting VC Fund
Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.
Show more
Investment focus
  • Solar, Energy, Medical
  • Series A, Seed, Series B
  • Canada, Spain
Portfolio highlights
  • SiXtron Advanced Materials — I found a great domain name for sale on Dan.com. Check it out!
  • Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
  • Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
BCN PEPTIDES VC Fund · Mediona, Catalonia, Spain
BCNPeptides is dedicated to pioneering R&D in cutting-edge bioactive peptides. We deliver tailor-made, high-quality solutions
Show more
Investment focus
  • Medical, Biopharma, Life Science
  • Funding Round
  • Spain
Portfolio highlights
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Fund+ VC Fund · Leuven, Vlaams-Brabant, Belgium
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • Belgium, United States, Spain
Portfolio highlights
  • eTheRNA immunotherapies — eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases.
  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Minoryx Therapeutics — Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
Stemar Capital VC Fund · London, Ontario, Canada
stemar capital private equity philippe costeletos
Show more
Investment focus
  • Genetics, Life Science, Biotechnology
  • Series A
  • Spain
Portfolio highlights
  • Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
GENESIS Biomed VC Fund · Barcelona, Catalonia, Spain · 2 investments in the past 12 months
Life sciences R&D, consulting and investment
Show more
Investment focus
  • Medical, Pharmaceutical, Biopharma
  • Seed, Pre-Seed, Funding Round
  • Spain
Portfolio highlights
  • Thytech — Thytech is a health tech company.
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
  • Ownmed Innovation — Ownmed Innovation is a Medtech spin-off that emerged from the collaboration between the Fundación para la Investigación Biomédica Hospital Gregorio Marañón (FIBHGM), the Instituto Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®,aimed at ostomate patients, with the purpose of restoring their ability to regain control over their continence.
Clave Capital VC Fund · Jardim Paulista, Sao Paulo, Brazil · 2 investments in the past 12 months
Clave Capital is an independent asset management company that specializes in investment strategy.
Show more
Investment focus
  • Biotechnology, Health Diagnostics, Health Care
  • Seed, Funding Round
  • Spain
Portfolio highlights
  • MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
  • Nanological — Nanological is a public research organization, that focuses on pathogen identification devices. Nanological is a team of biosensing experts including physicists, biologists, data scientists, finance and business development experts, and clinical validation specialists.
  • ADmit Therapeutics — ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.
Alma Mundi Ventures VC Fund · Madrid, Madrid, Spain
We back bold and purpose-driven founders.
Show more
Investment focus
  • Software, Insurance, InsurTech
  • Series A, Seed, Funding Round
  • Spain, United States, United Kingdom
Portfolio highlights
  • Life5 — Really easy life insurance. By humans, for humans.
  • Raincoat — Get the policy that offers you cash after the hurricane, without deductibles or having to make claims!
  • REVER — REVER is born to disrupt how eCommerce returns work by making them easier and faster for everyone.
Addition VC Fund · New York, New York, United States · 6 investments in the past 12 months
We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Series A, Series B, Series C
  • United States, Brazil, Canada
Portfolio highlights
  • Lekko — Dynamically configure your software without redeployments. With Lekko, engineers can focus on executing and safely hand off daily reconfigurations.
  • Chapter — Chapter provides consultation on the appropriate medical services to get. It offers advise on recommended medical card programs and benefits for every person. Chapter is based in New York.
  • Onehouse — Open storage, continuous pipelines, and automatic optimizations across table formats, engines, clouds. Automated data platform across Hudi, Delta, and Iceberg.
Fides Capital VC Fund · Madrid, Madrid, Spain · 2 investments in the past 12 months
Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)
Show more
Investment focus
  • Software, Automotive, Telecommunications
  • Seed, Pre-Seed, Series A
  • Spain
Portfolio highlights
  • Devengo — Light-speed transfers. Our Instant Payments API enables seamless integration to automate payouts to your customers in Europe and the UK.
  • Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
  • CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
Banc Sabadell and the Institut Català de Finances (ICF) VC Fund
Banc Sabadell and the Institut Català de Finances (ICF)
Show more
Investment focus
  • Wellness, Health Care, Medical Device
  • Pre-Seed, Series A, Debt Financing
  • Spain
Portfolio highlights
  • Cafler — Your car's personal assistant. Ask for a Cafler now, we move your car for you!
  • Amelia Virtual Care — Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.
  • Adan Medical Innovation — Adan Medical is a digital health company that develops integrated solutions for the management of anaphylaxis. Their mission is to improve the quality of life of patients that suffer severe allergic reactions requiring epinephrine.The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays twodifferent products in its pipeline: AnAPPhylaxis, a smart case for epinephrine auto-injectors connected to a mobile App, and WE SAVE, a smart box of epinephrine auto-injectors for public spaces.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 5 investments in the past 12 months
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
  • Exsilio Therapeutics — Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Pontifax VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in the past 12 months
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Israel, France
Portfolio highlights
  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
  • AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
New Enterprise Associates VC Fund · Menlo Park, California, United States · 40 investments in the past 12 months
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series B, Series A, Series C
  • United States, India, China
Portfolio highlights
  • MBX Biosciences — Homepage - MBX Biosciences
  • Brenig Therapeutics — Brenig Therapeutics develops therapies for neurodegenerative disorders.
  • Cardurion Pharmaceuticals — A Boston-based cardiovascular biotechnology company developing next-generation therapeutics for the treatment of heart failure and cardiovascular diseases.
UCB Ventures VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in the past 12 months
UCB Ventures is a €150 million strategic corporate venture fund
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Belgium, Spain
Portfolio highlights
  • ViaNautis — Precision Solutions
  • Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
  • Switch Therapeutics — Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).
Investors by industry
Investors by country
VC Funds in Spain by industry